Zobrazeno 1 - 10
of 229
pro vyhledávání: '"Ingo Kaczmarek"'
Publikováno v:
Vascular Health and Risk Management, Vol 2010, Iss default, Pp 27-30 (2010)
Amir K Bigdeli1, Andres Beiras-Fernandez1, Ingo Kaczmarek1, Christian Kowalski2, Michael Schmoeckel1, Bruno Reichart11Department of Cardiac Surgery, 2Department of Anesthesiology, Ludwig-Maximilians University, Munich, GermanyAbstract: Complications
Externí odkaz:
https://doaj.org/article/83cb41d18b934ffeaf28a90342724351
Autor:
Stephan W. Hirt, Christoph Bara, Markus J. Barten, Tobias Deuse, Andreas O. Doesch, Ingo Kaczmarek, Uwe Schulz, Jörg Stypmann, Assad Haneya, Hans B. Lehmkuhl
Publikováno v:
Journal of Transplantation, Vol 2013 (2013)
The evidence base relating to the use of everolimus in heart transplantation has expanded considerably in recent years, providing clinically relevant information regarding its use in clinical practice. Unless there are special considerations to take
Externí odkaz:
https://doaj.org/article/1778f3bc7fda49fcbe45dad40ac8c7a6
Autor:
Thomas Nickel, Susanne Pfeiler, Claudia Summo, Reinhard Kopp, Georgios Meimarakis, Zeljka Sicic, Marius Lambert, Korbinian Lackermair, Robert David, Andres Beiras-Fernandez, Ingo Kaczmarek, Michael Weis
Publikováno v:
Mediators of Inflammation, Vol 2012 (2012)
Introduction. Dendritic cells (DCs) and oxLDL play an important role in the atherosclerotic process with DCs accumulating in the plaques during plaque progression. Our aim was to investigate the role of oxLDL in the modulation of the DC homing-recept
Externí odkaz:
https://doaj.org/article/9a6213b294fd4b368667897111153bf6
Autor:
Christian Hagl, Matthias A. Koenig, Bruno Reichart, Sonja Guethoff, Katja Stroeh, Franz von Ziegler, Bruno Meiser, Ingo Kaczmarek, René Schramm, Eike Christian Kleinert, Carola Grinninger, Anna Rieger, Tanja Mayr
Publikováno v:
The Journal of Heart and Lung Transplantation. 34:634-642
Although acute cellular rejection after heart transplantation (HTX) can be controlled by full-dose calcineurin inhibitor (CNI)-based immunosuppressive regimens, cardiac allograft vasculopathy (CAV), nephrotoxicity, and malignancy remain ongoing probl
Autor:
Ingo Kaczmarek, Helmut Gulbins, Andres Beiras-Fernandez, Ina Schade, Oliver Deutsch, Sonja Guethoff, Bettina Jungwirth, Ute Seeland, Rebecka Hultgren, Brigitte Gansera, Jörg Seeburger, Sandra Eifert, Friedrich W. Mohr, Karolina Kublickiene, Bettina Pfannmueller, Elpiniki Katsari, Pascal M. Dohmen
Publikováno v:
Viszeralmedizin
Applying the gender lens to risk factors and outcome after adult cardiac surgery is of major clinical interest, as the inclusion of sex and gender in research design and analysis may guarantee more comprehensive cardiovascular science and may consecu
Autor:
Ralf Sodian, Hans D. Theiss, Ulrich Grabmaier, Nicole Kreissl, Christian Hagl, Gerhard Steinbeck, Ingo Kaczmarek, Wolfgang-Michael Franz
Publikováno v:
Artificial Organs. 38:231-234
In this retrospective study, we investigated the impact of preconditioning of the right ventricle with the calcium sensitizer levosimendan immediately before left ventricular assist device (LVAD) implantation on outcome and survival. Nine consecutive
Autor:
Ingo Kaczmarek, Andres Beiras-Fernandez, Felix Kur, S. Schleger, I. Seitz-Merwald, I. Kanzler
Publikováno v:
Transplantation Proceedings. 45:1846-1849
Introduction ATG-Fresenius, a purified rabbit polyclonal anti-human T-lymphocyte immunoglobulin is used for induction immunosuppression as well as prevention and treatment of acute rejection episodes among patients receiving solid organ transplants.
Publikováno v:
Zeitschrift für Herz-,Thorax- und Gefäßchirurgie. 27:180-186
In Deutschland sind ca. 240.000 Menschen von terminaler Herzinsuffizienz der Stadien III–IV in der Klassifikation der New York Heart Association (NYHA) betroffen. Die orthotope Herztransplantation stellt hier den einzigen kurativen Therapieansatz d
Autor:
Sebastian Sadoni, Marc-Michael Zaruba, Ingo Kaczmarek, Bruno Meiser, Thomas Nickel, Carola Grinninger, Andres Beiras-Fernandez, Christian Hagl, Ricarda Reimann
Publikováno v:
The Journal of Heart and Lung Transplantation. 32:277-284
Background Despite improvements in immunosuppressive therapy, the most advantageous combination for cardiac transplant recipients has not been established. This randomized controlled trial was performed to evaluate the efficacy and safety of 3 immuno
Autor:
Thomas Nickel, Sandra Eifert, Ingo Kaczmarek, Andres Beiras-Fernandez, Sieglinde Kofler, Amir K. Bigdeli, Sophia Horster, Bruno Meiser
Publikováno v:
Experimental and Clinical Transplantation. 10:368-374
Objectives Gender differences between donors and recipients might have an effect on outcome after heart transplantation. Literature and registries reveal controversial results. We reviewed 1000 heart transplantations at our center focusing on the inf